重复"定时并开始"测试:12秒的截止时间可以预测老年人住院相关功能衰退
Orly Gatenio-Hefling1, Roy Tzemah-Shahar1, Kfir Asraf2
1Faculty of Health and Social Welfare, University of Haifa, Haifa, Israel.
GeroScience
|July 16, 2024
概括
定时升级和启动 (TUG) 测试可以预测老年人住院相关功能衰退 (HAFD). 超过12秒的TUG得分表明HAFD的风险很大,可以进行早期干预.
科学领域:
- 老年学是一门学科.
- 康复医学 康复医学 康复医学
- 临床评估 临床评估
背景情况:
- 住院相关功能衰退 (HAFD) 是老年人面临的重大风险,影响他们的独立性和生活质量.
- 早期发现HAFD对于实施及时干预以减轻其影响至关重要.
- 在临床环境中对HAFD的当前风险评估通常是主观的,可能低估了实际风险.
研究的目的:
- 评估定时启动和启动 (TUG) 测试在预测老年人中HAFD的有效性,这些老年人在住院之前可以独立行走.
- 为了确定TUG测试的表现是否可以识别住院期间功能衰退风险较高的个体.
主要方法:
- 一项横截面研究包括310名住院于内科病房的老年人 (≥65岁).
- 住院相关功能衰退 (HAFD) 在入院和出院时使用修改后的巴特尔指数 (MBI) 进行评估.
- 在入院时进行了定时并进行 (TUG) 测试,结果与MBI变化,人口统计,查尔森并发症指数和ALFI-MMSE得分进行了分析.
主要成果:
- 在12秒以下完成TUG测试的老年人没有显著的功能下降 (MBI变化).
- 参与者花费超过12秒或无法完成TUG测试,证明了统计学上显著的HAFD.
- 调整为共变量的TUG测试有效地确定了有显著功能衰退风险的个体.
结论:
- 定时上路测试 (TUG) 是一种有价值的工具,用于查患有住院相关功能衰退风险的老年人.
- 将TUG测试集成到临床实践中可以促进早期识别需要预防性干预的患者.
- TUG测试提供了一个客观的措施来补充主观评估,并改善HAFD风险分层.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...